Article in American journal of physiology. Lung cellular and molecular physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Larissa A ShimodaDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0001-5987-1378
Nathan W BartlettViral Immunology and Respiratory Disease group, University of Newcastle, Newcastle, New South Wales, Australia.ORCID 0000-0002-2715-5163
Julie A BastaracheDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.ORCID 0000-0003-0458-6507
Carol Feghali-BostwickDivision of Rheumatology & Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0002-6750-6407
Susan J GunstDepartment of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, Indiana.ORCID 0000-0001-9836-4782
Wolfgang M KueblerInstitute of Physiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0003-4100-2961
Eric P SchmidtDivision of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, School of Medicine, University of Colorado, Aurora, Colorado.ORCID 0000-0002-7360-0504
Rory E MortyDepartment of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.ORCID 0000-0003-0833-9749
Funding
Smooth Muscle Mechanisms in Dynamic Airways PropertiesR01HL029289 · NHLBI · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI GUNST, SUSAN J. · 1986 to 2020
$7.3M
Aquaporin 1 and pulmonary hypertensionR01HL126514 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SHIMODA, LARISSA A. · 2015 to 2025
$4.5M
Na+/H+ exchange in pulmonary hypertensionR01HL073859 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SHIMODA, LARISSA A. · 2003 to 2020
$4.2M
MK2 and pulmonary hypertensionR01HL159906 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI DAMARLA, MAHENDRA, SHIMODA, LARISSA A. · 2021 to 2024
$3.0M
Role of pericytes in scleroderma skin and lung fibrosisR01HL133751 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI FEGHALI-BOSTWICK, CAROL A., SCHNAPP, LYNN M · 2017 to 2020
$2.0M
Mechanism of Action of Anti-Fibrotic PeptideR01HL121262 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FEGHALI-BOSTWICK, CAROL A. · 2017 to 2020
$1.5M
IGF-II regulates lung fibrosis in sclerodermaR01HL153195 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FEGHALI-BOSTWICK, CAROL A. · 2020 to 2023
$1.5M
Scleroderma Twin Study and analysis of Estrogen in patients with dcSScK24AR060297 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FEGHALI-BOSTWICK, CAROL A. · 2013 to 2025
$1.4M
Potential Protective Mechanisms of Tissue Factor in Acute Lung InjuryI01BX002288 · VA · VETERANS HEALTH ADMINISTRATION · PI BASTARACHE, JULIE ANNE · 2018 to 2021
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Promoting our early career members at · full record | OpenQuestion